Shares of CRH Medical Corp (NASDAQ:CRHM) have been assigned an average broker rating score of 1.00 (Strong Buy) from the one brokers that cover the stock, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy recommendation.
Brokerages have set a 1-year consensus price target of $6.35 for the company and are predicting that the company will post $0.05 EPS for the current quarter, according to Zacks. Zacks has also assigned CRH Medical Corp an industry rank of 105 out of 265 based on the ratings given to related companies.
A number of equities analysts have recently issued reports on the stock. Canaccord Genuity restated a “buy” rating on shares of CRH Medical Corp in a research note on Monday, July 11th. Zacks Investment Research lowered shares of CRH Medical Corp from a “buy” rating to a “hold” rating in a report on Monday, September 5th. RBC Capital Markets reaffirmed an “outperform” rating and issued a $6.50 target price on shares of CRH Medical Corp in a report on Saturday, October 8th. Finally, CIBC reaffirmed an “outperform” rating on shares of CRH Medical Corp in a report on Tuesday, September 13th.
Several large investors have recently bought and sold shares of the company. Hillsdale Investment Management Inc. bought a new stake in shares of CRH Medical Corp during the second quarter worth approximately $3,661,000. Stifel Financial Corp bought a new stake in shares of CRH Medical Corp during the second quarter worth approximately $3,051,000. Pacific Ridge Capital Partners LLC bought a new stake in shares of CRH Medical Corp during the second quarter worth approximately $1,985,000. Mackenzie Financial Corp bought a new stake in shares of CRH Medical Corp during the second quarter worth approximately $1,899,000. Finally, Sentry Investments Corp. raised its stake in shares of CRH Medical Corp by 1.9% in the second quarter. Sentry Investments Corp. now owns 386,300 shares of the company’s stock worth $1,943,000 after buying an additional 7,300 shares in the last quarter.
Shares of CRH Medical Corp (NASDAQ:CRHM) opened at 4.62 on Friday. The company has a 50 day moving average of $3.96 and a 200-day moving average of $3.61. CRH Medical Corp has a 12-month low of $2.15 and a 12-month high of $4.72.
CRH Medical Corp Company Profile
CRH Medical Corporation, formerly Medsurge Medical Products Corp., is a healthcare products and services company. The Company operates through segments, including the sale of medical products and the provision of anesthesia services. The Company specializes in the treatment of hemorrhoids utilizing its treatment protocol and technology.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with MarketBeat.com's FREE daily email newsletter.